LAVAL, Quebec, Oct. 26, 2015 /CNW/ -- J. Michael Pearson, Chairman and Chief Executive Officer of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX ), made the following statements on today's investor call.